In response to the COVID-19 pandemic, cancer researchers are making changes to clinical trials to ensure patient safety and protect the integrity of their work. Some changes, such as greater use of telemedicine, will likely continue into the future.
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2VvasTQ
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2VvasTQ